Next generation biopharmaceuticals are not uniform. Optimising production needs more than a generic, one-size-fits-all vector system.
From promoter recommendations to lead and back-up expression vectors in 11 weeks.
In-parallel testing of a wider combination of synthetic promoters for challenging proteins.
Promoter combinations and materials available off-the-shelf for use with well-behaved proteins.
Services may be selected in full, or as discrete elements to support individual requirements, development stage timing and resources. Intellectual property is secured as a matter of course throughout the project. Freedom to operate is assured through exclusive licence or assignment of IP to the customer to provide complete clarity and confidence from the outset.
